Together we will beat cancer

Donate

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO) annual meeting. Here’s a flavour of the some of the top research presented.

Read More

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

Read More

Scientists find cells in centre of tumours are most likely to spread

The new findings shed light on how cancer cells found in different parts of a tumour behave differently.

Read More

Research shows one size doesn’t fit all for cervical screening in the trans and non-binary community

Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.

Read More

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

Read More

Ovarian cancer screening trial did not save lives

In 1999, Menon joined Professor Ian Jacobs to set up the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 20 years later, the results are in.

Read More

‘Will cancer make me infertile?’ – That Cancer Conversation

This entry is part 1 of 1 in the series That Cancer Conversation

For the first episode of our new podcast, we explore cancer and infertility.

Read More

‘Never done before’ AI study could improve early detection of pancreatic cancer

Around 8 in 10 pancreatic cancer cases are currently diagnosed late in England and Wales.

Read More

Stressed out – the cancer cells that survive chemotherapy, but at a cost

A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.

Read More

Scientists developing new class of drug for leukaemia

Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year. 

Read More